SCHEMBL6888915

SCHEMBL6888915

CCN1CCC(C#N)(c2cc(C)ccn2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 1/20 0.41
CCR1 P32246 1/20 0.39
CCR5 P51681 1/20 0.39
CCR8 P51685 1/20 0.39
OPRM1 P35372 2/20 0.38
PRKCA P17252 1/20 0.37
PTPN2 P17706 1/20 0.37
HTR7 P34969 1/20 0.37
OPRD1 P41143 1/20 0.36
RAF1 P04049 2/20 0.35
BRAF P15056 2/20 0.35
PIK3CA P42336 1/20 0.34
OPRL1 P41146 1/20 0.34
KDM4E B2RXH2 1/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
SLC6A9 P48067 1/20 0.34
CHRM1 P11229 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16546672 0.86 ADRA1A (0.39) ADRA1ACCR1CCR5CCR8OPRM1
SCHEMBL6884199 0.85 OPRM1 (0.54) ADRA1ACCR1CCR5CCR8OPRM1
SCHEMBL13806000 0.84 UHRF1 (0.41) ADRA1ACCR1CCR5CCR8OPRM1
SCHEMBL14703175 0.83 KMT2A (0.44) ADRA1ACCR1CCR5CCR8PRKCA
SCHEMBL13805993 0.81 UHRF1 (0.38) ADRA1ACCR1CCR5CCR8OPRM1
SCHEMBL6887265 0.81 ADRA1A (0.52) ADRA1ACCR1OPRM1PRKCAPTPN2
SCHEMBL6888922 0.80 ADRA1A (0.41) ADRA1AOPRM1PRKCAPTPN2HTR7
SCHEMBL6888271 0.79 CCR1 (0.42) CCR1CCR5CCR8OPRM1OPRD1
SCHEMBL16549577 0.78 CYP2D6 (0.36) ADRA1AOPRM1PRKCAPTPN2HTR7
SCHEMBL2220946 0.77 SYK (0.38) ADRA1ACCR1CCR5CCR8OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2501231-B1 QUINOLIZIDINONE CARBOXAMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS MERCK SHARP & DOHME (US) 2016-12-21 EP disclosed
US-9206200-B2 N-linked lactam M1 receptor positive allosteric mogulators MERCK SHARP & DOHME CORP. (US) 2015-12-08 US disclosed
US-20150065498-A1 N-LINKED LACTAM M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS MERCK SHARP & DOHME LLC 2015-03-05 US disclosed
US-8754220-B2 Quinolizidinone carboxamide M1 receptor positive allosteric modulators MERCK SHARP & DOHME CORP. (US) 2014-06-17 US disclosed
US-8754220-B2 Quinolizidinone carboxamide M1 receptor positive allosteric modulators MERCK SHARP & DOHME CORP. (US) 2014-06-17 US disclosed
US-20120232076-A1 QUINOLIZIDINONE CARBOXAMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS MERCK SHARP & DOHME LLC 2012-09-13 US disclosed
US-20120232076-A1 QUINOLIZIDINONE CARBOXAMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS MERCK SHARP & DOHME LLC 2012-09-13 US disclosed
WO-2011062853-A1 QUINOLIZIDINONE CARBOXAMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS MERCK SHARP & DOHME CORP. (US) 2011-05-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150065498-A1 N-LINKED LACTAM M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS CHRM1, OPRL1, OPRM1 ADRA1A 109/4885CCR1 3602/4885CCR5 3193/4885
US-20120232076-A1 QUINOLIZIDINONE CARBOXAMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS CHRM1, CHRM2, CHRM4 ADRA1A 62/4885CCR1 3436/4885CCR5 1579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.